MinervaX provides clinical and leadership update Completed enrolment of 150 pregnant women in a Phase 2 study in South Africa and dosing started in an additional 50 pregnant women in Uganda, as part of same study Phase 1 booster study started in the United Kingdom Regulatory approval obtained from Danish Medicines A.